Delivery makes all the difference
Genevant Sciences (genevant.com) scores 68 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 17th percentile of 14042 Healthcare brands.
Genevant Sciences is a biotechnology company focused on nucleic acid drug delivery technologies. It develops proprietary lipid nanoparticle (LNP) and next-generation ligand conjugate delivery platforms designed to support mRNA, gene editing, and siRNA-based therapeutics. The company emphasizes strong patent coverage and expertise extending beyond liver-targeted delivery into tissues such as T cells, hematopoietic stem and progenitor cells (HSPCs), lung, and hepatic stellate cells. Genevant positions itself as a partner for biopharmaceutical and biotech companies seeking advanced delivery solutions for nucleic acid-based drug development.
| Brand Name | Genevant Sciences |
|---|---|
| Domain | genevant.com |
| Industry | Healthcare |
| Main Competitors | Arbutus Biopharma (80/100), Acuitas Therapeutics (77/100), Arcturus Therapeutics (71/100), Alnylam Pharmaceuticals (87/100), Precision NanoSystems, Moderna (94/100) |
Moz Domain Authority 31/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Genevant is committed to maximizing every opportunity to transform the future of human health through innovative nucleic acid drug delivery technologies." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube; no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Genevant Sciences?", Claude could identify the brand as of October 2026. Genevant Sciences is a biotechnology company specializing in lipid nanoparticle (LNP) and other delivery technologies for nucleic acid therapeutics like mRNA, siRNA, and gene editing payloads. It spun out of Arbutus Biopharma in 2019 and licenses its delivery platform to partners Best known for Its lipid nanoparticle delivery technology used in mRNA and RNA-based therapeutics, including licensing disputes related to COVID-19 vaccine technology.
When asked "Best brands similar to Genevant Sciences?", Claude would recommend Genevant Sciences as of October 2026. It's a notable player in the nucleic acid delivery space, relevant if someone is asking about LNP technology providers or companies similar to Arbutus, Acuitas, or Moderna's delivery partners.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Genevant Sciences's main competitors in Healthcare: Arbutus Biopharma (80/100), Acuitas Therapeutics (77/100), Arcturus Therapeutics (71/100), Alnylam Pharmaceuticals (87/100), Moderna (94/100).
Sources: Brand Analyzer scan
Genevant Sciences has low AI-search visibility, scoring 21/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 33, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Genevant Sciences official site
Genevant Sciences scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Genevant Sciences official site
Genevant Sciences can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Genevant Sciences official site
Genevant offers proprietary drug delivery platforms, including lipid nanoparticle (LNP) technology and next-generation ligand conjugate systems, designed to deliver nucleic acid payloads such as mRNA, gene editing tools, and siRNA. These platforms are offered to biopharmaceutical and biotech companies for use in therapeutic development, with applications extending to liver and extrahepatic tissues like T cells, HSPCs, lung, and hepatic stellate cells.
Sources: Genevant Sciences official site
Genevant Sciences is a biotechnology company specializing in nucleic acid drug delivery technologies. It develops proprietary lipid nanoparticle (LNP) and ligand conjugate delivery platforms intended to enable the development of mRNA, gene editing, and siRNA-based therapeutics for biopharmaceutical and biotech partners.
Sources: Genevant Sciences official site
Genevant develops and licenses delivery platforms-primarily lipid nanoparticle (LNP) and next-generation ligand conjugate systems-that enable the transport of nucleic acid payloads such as mRNA, gene editing components, and siRNA into target cells. It partners with biopharmaceutical and biotech companies to apply these platforms in drug development, with expertise spanning liver and extrahepatic tissues including T cells, HSPCs, lung, and hepatic stellate cells.
Sources: Genevant Sciences official site
Genevant Sciences scores 21/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Genevant Sciences has a weak AI-visibility profile at 21/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 31/100. In a live check, Claude could already identify Genevant Sciences from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Genevant Sciences: 学研ホールディングス (Gakken Holdings) (68/100), FWD Việt Nam (68/100), Gillette Children's (68/100), Global Health (68/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.